Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31108901 | 0.87 | ACACB (0.48) | CYP4F2CYP4A11ACACBACACATBXAS1 | |
| SCHEMBL31108831 | 0.85 | CYP4F2 (0.63) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL31108832 | 0.85 | CYP4F2 (0.63) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL31108841 | 0.85 | CYP4F2 (0.63) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL31108835 | 0.85 | CYP4F2 (0.63) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL31108872 | 0.83 | CYP4F2 (0.60) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL3279511 | 0.82 | CYP4F2 (0.52) | CYP4F2CYP4A11HTTMEN1MAPT | |
| SCHEMBL17772118 | 0.79 | ACACB (0.35) | CYP4F2CYP4A11ACACBACACA | |
| SCHEMBL31108852 | 0.76 | CYP4F2 (0.58) | CYP4F2CYP4A11ACACBACACAHTT | |
| SCHEMBL31108879 | 0.74 | CYP4F2 (0.63) | CYP4F2CYP4A11ACACBACACAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695266-A1 | SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF | Meta Pharmaceuticals (HK) Limited (HK) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024213143-A1 | SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF | META PHARMACEUTICALS (HK) LIMITED (CN) | 2024-10-17 | — | — | WO | disclosed |